Your browser doesn't support javascript.
loading
APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
Singh, Neha Atulkumar; Tosakulwong, Nirubol; Graff-Radford, Jonathan; Machulda, Mary M; Pham, Nha Trang Thu; Sintini, Irene; Weigand, Stephen D; Schwarz, Christopher G; Senjem, Matthew L; Carrasquillo, Minerva M; Ertekin-Taner, Nilufer; Jack, Clifford R; Lowe, Val J; Josephs, Keith A; Whitwell, Jennifer L.
Afiliação
  • Singh NA; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Tosakulwong N; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Graff-Radford J; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Machulda MM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Pham NTT; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Sintini I; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Weigand SD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Schwarz CG; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Senjem ML; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Carrasquillo MM; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Ertekin-Taner N; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Jack CR; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Lowe VJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Josephs KA; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Alzheimers Dement ; 2022 Jun 12.
Article em En | MEDLINE | ID: mdl-35691047
ABSTRACT

INTRODUCTION:

Apolipoprotein E (APOE) ε4 is an important genetic risk factor for typical Alzheimer's disease (AD), influencing brain volume and tau burden. Little is known about its influence in atypical presentations of AD.

METHODS:

An atypical AD cohort of 140 patients diagnosed with either posterior cortical atrophy or logopenic progressive aphasia underwent magnetic resonance imaging and positron emission tomography. Linear mixed effects models were fit to assess the influence of APOE Îµ4 on cross-sectional and longitudinal regional metrics.

RESULTS:

At baseline, APOE ε4 carriers had smaller hippocampal and amygdala volumes and greater tau standardized uptake volume ratio in the hippocampus and entorhinal cortex compared to non-carriers while longitudinally, APOE ε4 non-carriers showed faster rates of atrophy and tau accumulation in the entorhinal cortex, with faster tau accumulation in the hippocampus.

DISCUSSION:

APOE ε4 influences patterns of neurodegeneration and tau deposition and was associated with more medial temporal involvement, although there is evidence that non-carriers may be catching up over time.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article